Clinical Trial Update: Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating dextromethorphan and silymarin in chronic kidney disease patients with proteinuria; status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Silymarin (silymarin)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Proteinuria | Phase 3 | Status: UNKNOWN